Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19

出版年份 2020 全文链接

标题

作者

关键词

Complement, Lectin pathway, MASP2, Coronavirus, COVID-19, Eculizumab

出版物

Volume 219, Issue -, Pages 108555

出版商

Elsevier BV

发表日期

2020-08-07

DOI

10.1016/j.clim.2020.108555

联系作者

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started